Human Research Ethics Committee

Adlai Nortye Receives HREC Approval for AN4035 Phase I Trial

SINGAPORE and NORTH BRUNSWICK, N.J., Aug. 3, 2026 Adlai Nortye Ltd. has advanced its oncology pipeline after submitting a...

By cGxPwire Editor
August 4, 2026

Bio-Pharma

CAMP4 Therapeutics Receives Australian Clearance for First-in-Human CMP-002 Trial

CAMBRIDGE, Mass., July 27, 2026 CAMP4 Therapeutics announced that it has received regulatory clearance from Australia’s Therapeutic Goods Administration...

By cGxPwire Editor
July 28, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Human Research Ethics Committee

Adlai Nortye Receives HREC Approval for AN4035 Phase I Trial

CAMP4 Therapeutics Receives Australian Clearance for First-in-Human CMP-002 Trial